Phase 2 Trial Shows Patara’s PA101 May Reduce Chronic Cough in IPF Patients

News

Phase 2 clinical trial data demonstrated that Patara Pharma‘s investigative anti-inflammatory drug PA101 has the potential to significantly reduce chronic coughing in patients with idiopathic pulmonary fibrosis (IPF). This finding ... Read more

July 6, 2016July 6, 2016

Ibuprofen, Inhaled at High Doses, May Be a Way of Treating Cystic Fibrosis

Cystic Fibrosis, News, Pneumonia

You have probably heard of ibuprofen, a common drug-store medication to help with headaches or sprained ankles. Ibuprofen is an anti-inflammatory drug, which is also one of the reasons it ... Read more